All Industry articles
View all stories with this category.
-
BusinessThe rise of venture philanthropy
More and more charities are investing in companies, and looking for returns on that investment, as an alternative to traditional grants
-
Business
Nitrosamine contamination withdrawals spread to new drugs
After ranitidine recalls, EU regulators instruct companies to review all their products for potential impurities
-
Business
Sixth in a line of Alzheimer’s drugs fails in trials
Treatments designed to stop amyloid peptide formation all seem to cause cognitive impairment rather than prevent it
-
Business
Leaking filter caused deadly explosion at US plant
Blast that killed one and injured 30 others at a KMCO facility in Texas was caused by hole in pipe component
-
Opinion
Is bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
Business
Chemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided
-
Opinion
Embracing structural disorder
Medicinal chemists need to overcome their fear of fuzzy proteins
-
Business
Industry delves into the digital toolbox
Chemical companies are making their plants and processes increasingly digital, data-driven and interconnected
-
Business
Aquaffirm’s enzymatic arsenic sensors
Cheap, disposable electrochemistry test strips help communities steer clear of contaminated wells
-
Business
Landmark ruling in Oklahoma opioid lawsuit
J&J judged responsible for ‘public nuisance’ in first case to go to trial
-
Sponsored
RSSL experts on the science behind food and pharma
Three scientists, whose contributions help world-leading brands and SMEs develop and supply innovative, safe products, share their experiences working in the labs of contract research company Reading Scientific Services Limited (RSSL)
-
Opinion
Will Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
News
Data manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
Opinion
Has x-ray had its day?
Will the giant of structure determination be toppled by blasts from electron beams?
-
Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
Business
Enhancing solvents' sustainability
Increased recycling and replacing toxic solvents with greener alternatives will reduce environmental impact
-
Business
Pfizer’s Upjohn to merge with Mylan
Deal combines Pfizer’s off-patent drug portfolio with Mylan’s generics
-
Business
US ditches chlorpyrifos ban for food crops
Environmental Protection Agency says evidence of harm from food residues is insufficient
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
Business
Curbing industry’s carbon emissions
Replacing fossil-fuelled furnaces with renewable electrical heating and cutting carbon from some heavy industries could make a serious dent in climate targets
